Publications by authors named "Cristina Bittante"
Article Synopsis
- - The study analyzed diabetic patients with Charcot neuro-osteoarthropathy (CNO), a serious complication of diabetes, being treated at a specialized diabetic foot clinic from early 2019 to late 2022.
- - Out of 43 patients, the average age was around 57, predominantly male, and most had type 2 diabetes for over 20 years, with a significant portion also having peripheral artery disease.
- - Results showed a high remission rate of 93% after treatment, with an average remission time of about 5.6 months, and very low rates of major amputations (2.3%) or surgical interventions (7%).
Article Synopsis
- Nephropathy is a serious complication of type 2 diabetes (T2DM) linked to increased albuminuria and decreased glomerular filtration rate (GFR), with varying progression rates to severe kidney disease among patients.
- In a study of 410 newly diagnosed T2DM patients, researchers tracked changes in eGFR over an average of 12.4 years, finding that about 11.4% experienced rapid declines in eGFR.
- The study concluded that albuminuria is a strong predictor of rapid eGFR decline, which could help in identifying patients at risk and potentially slowing the progression of kidney damage.
Insulin dose has been found to associate to several cardiometabolic risk factors in type 1 diabetes. Changes over time in body weight and composition may partly explain this association. However, no data are available on the relationship between insulin dose and echocardiographic parameters of both systolic and diastolic function in type 1 diabetes.
View Article and Find Full Text PDFContext: Diabetes reduces the levels of circulating progenitor cells (CPCs) and endothelial progenitor cells (EPCs), which promote vascular repair and are inversely correlated with cardiovascular risk.
Objective: The objective of the study was to test whether CPC/EPC levels predict onset/progression of microangiopathy in a cohort of type 2 diabetic (T2D) patients.
Design: This was a pseudoprospective study with a 3.